TransMedics

TMDX · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

R&D and Clinical Trials

$20.7M

Previous year: $16.5M

+25.7%

SG&A Expense

$51.4M

Previous year: $46.9M

Loading...

TransMedics

Unlock previous datapoints

Upgrade

TransMedics

Unlock previous datapoints

Upgrade

TransMedics Revenue by Segment

Revenue by Segment

Net Product Revenue

CapyFin.com

Service Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.45B

P/E Ratio

35.31

Sector

N/A

Industry

N/A

52-Week High

$150

52-Week Low

$67.8

Gross Margin

58%

R&D and Clinical Trials

$20.7M

SG&A Expense

$51.4M

Total Operating Expenses

$72.1M

Stock Compensation Expense

$9.1M

Products

Get in Touch

Resources

TransMedics

TransMedics

TransMedics

TransMedics Revenue by Segment

Revenue by Segment

Net Product Revenue

Service Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics